Informa plc (LON:INF) Receives Consensus Rating of “Buy” from Analysts

Shares of Informa plc (LON:INF) have been given an average recommendation of “Buy” by the six research firms that are currently covering the firm, Marketbeat reports. Six investment analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is GBX 1,135.

INF has been the topic of several research reports. JPMorgan Chase & Co. lowered their price objective on shares of Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating on the stock in a report on Thursday, July 2nd. Berenberg Bank lifted their price target on Informa from GBX 965 to GBX 1,040 and gave the stock a “buy” rating in a report on Friday, July 31st. Citigroup boosted their target price on shares of Informa from GBX 990 to GBX 1,090 and gave the company a “buy” rating in a research note on Wednesday, August 12th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 1,140 price target on shares of Informa in a research report on Friday, July 31st.

Informa Trading Down 1.9%

LON INF opened at GBX 884.60 on Tuesday. The company has a quick ratio of 1.70, a current ratio of 0.55 and a debt-to-equity ratio of 64.99. Informa has a 52 week low of GBX 719 and a 52 week high of GBX 1,000. The business has a 50 day moving average price of GBX 897.88 and a 200-day moving average price of GBX 835.86. The company has a market cap of £11.06 billion, a price-to-earnings ratio of 51.73, a P/E/G ratio of 0.75 and a beta of 0.68.

Informa (LON:INF) last issued its earnings results on Thursday, July 30th. The company reported GBX 26.70 earnings per share (EPS) for the quarter. Informa had a return on equity of 3.90% and a net margin of 5.43%. As a group, equities analysts expect that Informa will post 59.3240265 earnings per share for the current fiscal year.

Informa Company Profile

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.